Terms: = Ovarian cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1
290 results:
1. Combined inhibition of HER2 and vegfr synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer.
Li W; Zhang K; Wang W; Liu Y; Huang J; Zheng M; Li L; Zhang X; Xu M; Chen G; Wang L; Zhang S
J Exp Clin Cancer Res; 2024 Feb; 43(1):56. PubMed ID: 38403634
[TBL] [Abstract] [Full Text] [Related]
2. Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer.
Arai H; Yang Y; Baca Y; Millstein J; Denda T; Ou FS; Innocenti F; Takeda H; Kubota Y; Doi A; Horie Y; Umemoto K; Izawa N; Wang J; Battaglin F; Jayachandran P; Algaze S; Soni S; Zhang W; Goldberg RM; Hall MJ; Scott AJ; Hwang JJ; Lou E; Weinberg BA; Marshall J; Goel S; Xiu J; Michael Korn W; Venook AP; Sunakawa Y; Lenz HJ
Eur J Cancer; 2024 Apr; 201():113914. PubMed ID: 38359495
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of VEGF/vegfr inhibitors for platinum-resistant ovarian cancer: a systematic review and meta-analysis of randomized controlled trials.
Huang D; Ke L; Cui H; Li S; Sun F
BMC Womens Health; 2024 Jan; 24(1):34. PubMed ID: 38218775
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
5. A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation analysis.
Liu Y; Wang W; Yin R; Zhang Y; Zhang Y; Zhang K; Pan H; Wang K; Lou G; Li G; Zhang R; Li K; Rao J; Zhang B; Wang Y; Wang Q; Gao Y; Li H
BMC Med; 2023 Sep; 21(1):376. PubMed ID: 37775744
[TBL] [Abstract] [Full Text] [Related]
6. A novel chiral oxazoline copper(II)-based complex inhibits ovarian cancer growth
Fan R; Wei JC; Xu BB; Jin N; Gong XY; Qin XY
Dalton Trans; 2023 Aug; 52(33):11427-11440. PubMed ID: 37539728
[TBL] [Abstract] [Full Text] [Related]
7. In Vivo Ultrasound Molecular Imaging in the Evaluation of Complex ovarian Masses: A Practical Guide to Correlation with Ex Vivo Immunohistochemistry.
Antil N; Wang H; Kaffas AE; Desser TS; Folkins A; Longacre T; Berek J; Lutz AM
Adv Biol (Weinh); 2023 Aug; 7(8):e2300091. PubMed ID: 37403275
[TBL] [Abstract] [Full Text] [Related]
8. Dynamic contrast-enhanced MRI to characterize angiogenesis in primary epithelial ovarian cancer: An exploratory study.
Lindgren A; Anttila M; Arponen O; Hämäläinen K; Könönen M; Vanninen R; Sallinen H
Eur J Radiol; 2023 Aug; 165():110925. PubMed ID: 37320880
[TBL] [Abstract] [Full Text] [Related]
9. Mass Spectrometry-Based Proteomics of Epithelial ovarian cancers: A Clinical Perspective.
Qian L; Sun R; Xue Z; Guo T
Mol Cell Proteomics; 2023 Jul; 22(7):100578. PubMed ID: 37209814
[TBL] [Abstract] [Full Text] [Related]
10. Angiogenesis inhibitors for the treatment of epithelial ovarian cancer.
Gaitskell K; Rogozińska E; Platt S; Chen Y; Abd El Aziz M; Tattersall A; Morrison J
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD007930. PubMed ID: 37185961
[TBL] [Abstract] [Full Text] [Related]
11. Molecular cluster mining of high-grade serous ovarian cancer via multi-omics data analysis aids precise medicine.
Cai D; Liu T; Fang J; Liu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9151-9165. PubMed ID: 37178426
[TBL] [Abstract] [Full Text] [Related]
12. Genetic Characterization of ovarian Tumor Tissues from Patients with Epithelial ovarian cancer in a Philippine Tertiary Hospital: A Descriptive Study.
Lintao RCV; Padua AJP; Nakura Y; Llamas-Clark EF; Yanagihara I
Asian Pac J Cancer Prev; 2023 Apr; 24(4):1187-1197. PubMed ID: 37116140
[TBL] [Abstract] [Full Text] [Related]
13. Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer.
Pan Z; Luo Z; He H; Chen Y; Zhao B; Yang Z; Li L
J Ovarian Res; 2023 Feb; 16(1):44. PubMed ID: 36823642
[TBL] [Abstract] [Full Text] [Related]
14. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
15. An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer.
Wieser V; Tsibulak I; Reimer DU; Zeimet AG; Fiegl H; Hackl H; Marth C
Gynecol Oncol; 2023 Mar; 170():290-299. PubMed ID: 36758419
[TBL] [Abstract] [Full Text] [Related]
16. [Anti-angiogenic drugs and hypertension: from multidisciplinary collaboration to greater care].
Tunesi F; Simonini M; Sabetta G; Bergamini A; Cioffi R; Raiabiotti E; Manunta P; Vezzoli G; Mangili G; Lanzani CL
G Ital Nefrol; 2022 Dec; 39(6):. PubMed ID: 36655833
[TBL] [Abstract] [Full Text] [Related]
17. Carboplatin enhances lymphocyte-endothelial interactions to promote CD8
Mark J; Fisher DT; Kim M; Emmons T; Khan ANMN; Alqassim E; Singel K; Mistarz A; Lugade A; Zhan H; Yu H; Segal B; Lele S; Frederick P; Kozbor D; Skitzki J; Odunsi K
Gynecol Oncol; 2023 Jan; 168():92-99. PubMed ID: 36410228
[TBL] [Abstract] [Full Text] [Related]
18. Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis.
Zhao G; Song D; Wu J; Yang S; Shi S; Cui X; Ren H; Zhang B
Front Immunol; 2022; 13():955091. PubMed ID: 36052059
[TBL] [Abstract] [Full Text] [Related]
19. The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and vegfr in ovarian cancer cells.
Momen Razmgah M; Ghahremanloo A; Javid H; AlAlikhan A; Afshari AR; Hashemy SI
Mol Biol Rep; 2022 Oct; 49(10):9307-9314. PubMed ID: 35960409
[TBL] [Abstract] [Full Text] [Related]
20. Anlotinib combined with TQB2450 in patients with platinum-resistant or -refractory ovarian cancer: A multi-center, single-arm, phase 1b trial.
Lan CY; Zhao J; Yang F; Xiong Y; Li R; Huang Y; Wang J; Liu C; Bi XH; Jin HH; Meng J; Zhao WH; Zhang L; Wang YF; Zheng M; Huang X
Cell Rep Med; 2022 Jul; 3(7):100689. PubMed ID: 35858589
[TBL] [Abstract] [Full Text] [Related]
[Next]
